Spontaneous ascitic infection in different cirrhotic groups: Prevalence, risk factors and the efficacy of cefotaxime therapy

European Journal of Gastroenterology and Hepatology

Volumn 9, Issue 1, 1997, Pages 71-76

  Kaymakoglu, Sabahattin ^a   Eraksoy, Haluk ^a   Ökten, Atilla ^a   Demir, Kadir ^a   Çalangu, Semra ^a   Çakaloglu, Yilmaz ^a   Boztas, Güngör ^a   Besisik, Fatih ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Cefotaxime; Liver cirrhosis; Spontaneous ascitic infection

Indexed keywords

ANTIBIOTIC AGENT; BILIRUBIN; CEFOTAXIME; PROTEIN;

ADULT; ALCOHOLISM; ARTICLE; ASCITES; BACTERIAL PERITONITIS; BACTERIUM CULTURE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; DELTA AGENT HEPATITIS; DISEASE PREDISPOSITION; DRUG EFFICACY; ESCHERICHIA COLI; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LIVER CIRRHOSIS; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PARACENTESIS; PRIORITY JOURNAL; RISK FACTOR;

EID: 0031035148     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199701000-00017     Document Type: Article

References (26)

1. Cally WR, Strauss E: A prospective study of bacterial infections in patients with cirrhosis. J Hepatol 1993, 18:353-358.
2. Correia JP, Conn HO: Spontaneous bacterial peritonitis in cirrhosis: endemic or epidemic? Med Clin North Am 1975, 59:963-981.
3. Runyon BA: Pathogenesis and diagnosis of spontaneous bacterial peritonitis in cirrhosis. In Therapy in Liver Diseases. Edited by Rodes J, Arroyo V. Barcelona: Doyma; 1992:388-396.
4. Rimola A, Soto R, Borry F, Arroyo V, Piera C, Rodes J: Reticuloendothelial system phagocytic activity in cirrhosis and its relationship to bacterial infections and prognosis. Hepatology 1984, 4:53-58.
5. Runyon BA: Low protein concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis. Gastroenterology 1986, 91:1343-1346.
6. Tito L, Rimola A, Gines P, Llach J, Arroyo V, Rodes J: Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology 1988, 8:27-31.
7. Andreu M, Sola R, Sitges-Serra A, Alia C, Gallen M, Vila MC, et al.: Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites. Gastroenterology 1993, 104:1133-1138.
8. Pinzello G, Simonetti RG, Craxi A, Piazza SD, Spano C, Pagliaro L: Spontaneous bacterial peritonitis: a prospective investigation in predominantly nonalcoholic cirrhosis patients. Hepatology 1983, 3:545-549.
9. Attali P, Turner K, Pelletier G, Ink O, Etienne JP: pH of ascitic fluid: diagnostic and prognostic value in cirrhotic and noncirrhotic patients. Gastroenterology 1986, 90:1255-1260.
10. Almdal TP, Skinhoj P: Spontaneous bacterial peritonitis in cirrhosis: incidence, diagnosis and prognosis. Scand J Gastroenterol 1987, 22:295-300.
11. Hurwich DB, Lindor KD, Hay JE, Gross JB, Kaese D, Rakela J: Prevalence of peritonitis and the ascitic fluid protein concentration among chronic liver disease patients. Am J Gastroenterol 1993, 88:1254-1257.
12. Felisart J, Rimola A, Arroyo V, Perez-Ayuso RM, Quintero E, Gines P, et al.: Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infection. Hepatology 1985, 5:457-462.
13. Ariza J, Xiol X, Esteve M, Baneres FF, Linares J, Alonso T, et al.: Aztreonam vs. cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patients. Hepatology 1991, 14:91-98.
14. Todo S, Demetris AJ, Thiel DV, Teperman L, Fung JJ, Starzl TE: Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 1991, 13:619-626.
15. Eason JD, Freeman RB, Rohrer RJ, Lewis WD, Jenkins R, Dienstag J, et al.: Should liver transplantation be performed for patients with hepatitis B? Transplantation 1994, 57:1588-1593.
16. Crippin J, Foster B, Carlen S, Borcich A, Bodenheimer H: Retransplantation in hepatitis B - a multicenter experience. Transplantation 1994, 57:823-826.
17. Child CG, Turcotte JG: Surgery and portal hypertension. In The Liver and Portal Hypertension. Edited by Child CG. Philadelphia: WB Saunders; 1964:1-85.
18. Runyon BA, Canawati HN, Akriviadis EA: Optimization of ascitic fluid culture technique. Gastroenterology 1988, 95:1351-1355.
19. Castellote J, Xiol X, Verdaguer R, Ribes J, Guardiola J, Gimenez A, et al.: Comparison of two ascitic fluid culture methods in cirrhotic patients with spontaneous bacterial peritonitis. Am J Gastroenterol 1990, 85:1605-1608.
20. Toledo C, Salmeron J-M, Rimola A, Navasa M, Arroyo V, Llach J, et al.: Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology 1993, 17:251-257.
21. Sorell WT, Quigley EMM, Jin G, Johnson TJ, Rikkers LF: Bacterial translocation in the portal hypertensive rat: studies in basal conditions and on exposure to hemorrhagic shock. Gastroenterology 1993, 104:1722-1726.
22. Rimola A, Bory F, Teres J, Perez-Ayuso RM, Arroyo V, Rodes J: Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage. Hepatology 1985, 5:463-467.
23. Grange JD, Amiot X, Grange V, Gutmann L, Biour M, Bodin F, et al.: Amoxicillin-clavulanic acid therapy of spontaneous bacterial peritonitis: a prospective study of twenty-seven cases in cirrhotic patients. Hepatology 1990, 11:360-364.
24. Gomez-Jimenez J, Ribera E, Gasser I, Artaza MA, Del Valle O, Pahissa A, et al.: Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients. Antimicrob Agents Chemother 1993, 37:1587-1592.
25. Runyon BA, McHutchison JG, Antillon MR, Akriviadis EA, Montano AA: Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients. Gastroenterology 1991, 100:1737-1742.
26. Llovet JM, Planas R, Morillas R, Quer JC, Cabre E, Boix J, et al.: Short-term prognosis of cirrhotics with spontaneous bacterial peritonitis: multivariate study. Am J Gastroenterol 1993, 88:388-392.